Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
ID: 343473Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $75K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a Limited Competition Small Grant Program (R03) aimed at supporting K01, K08, K23, and K25 awardees. This program provides NIDDK-supported recipients the opportunity to apply for small grant support during the latter years of their career development awards, with the objective of enhancing their research capabilities and facilitating their transition to independent investigator status. The funding, which can support grants of up to $75,000 annually for a maximum of two years, is intended for pilot studies, feasibility projects, or secondary data analyses, aligning with the NIH's mission to promote scientific research that advances public health. Interested applicants must submit their proposals by September 7, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a Limited Competition Small Grant Program (R03) aimed at supporting K01, K08, K23, and K25 awardees. This program provides NIDDK-supported recipients the opportunity to apply for small grant support during the latter years of their career development awards. The initiative seeks to enhance the recipients' research capabilities and facilitate their transition to independent investigator status. The funding is intended for pilot studies, feasibility projects, or secondary data analyses, and can support grants of up to $75,000 annually for a maximum of two years. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities. However, the program is strictly limited to current K awardees who have not yet succeeded in competing for an R01 or equivalent grant. Applications must be well-structured and adhere to specific guidelines regarding format, submission processes, and required information. This funding initiative aligns with the NIH's mission to promote scientific research that advances public health, marking a concerted effort to develop early-career researchers into fully independent investigators.
    Similar Opportunities
    Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of specific NIDDK career development awards (K01, K08, K23, K25) to support their research during the latter years of their awards. This program is designed to enhance the transition to independent research by allowing these recipients to conduct pilot studies, secondary analyses, and other small projects, which are crucial for generating publications and data necessary for future R01 applications. The grant provides direct costs of up to $75,000 per year for a maximum of two years, with applications required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of the review process. Interested applicants should note that the submission period opens on January 16, 2025, with subsequent deadlines through January 2028, and can direct inquiries to grantsinfo@nih.gov for further information.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program aimed at recipients of NIAMS K01, K08, K23, and K25 awards, providing funding opportunities to enhance their research capabilities. This program allows eligible applicants to apply for Small Grant (R03) funding, which offers up to $100,000 for a two-year period to support pilot studies, secondary data analyses, and small-scale research projects, specifically excluding clinical trials. The initiative is designed to facilitate the transition of early-career scientists to independent investigator status, ultimately encouraging them to pursue R01 grants. Interested applicants must adhere to specific application guidelines, with submission dates beginning January 19, 2025, and a complete application deadline of February 20, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition Small Grant Program (R03) aimed at supporting current or recently completed NHLBI K01, K08, K23, and K25 awardees in enhancing their research capabilities as they transition to independent investigator roles. This funding opportunity allows eligible applicants to receive up to $75,000 per year for short-term research projects that can be completed within two years, focusing on activities such as pilot studies, proof of concept evaluations, and methodological development that generate preliminary data for future R01 applications. The program emphasizes the importance of fostering a diverse scientific workforce and is open for applications from January 13, 2023, with a closing date of January 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a Limited Competition Small Grant Program aimed at supporting current and recently completed K01, K08, K23, and K25 award recipients. This funding opportunity, designated as RFA-HL-25-011, allows eligible applicants to secure up to $75,000 per year for projects lasting up to two years, with the goal of generating preliminary data for subsequent R01-equivalent applications. The program is particularly focused on advancing early-stage investigators towards independent research careers, emphasizing the inclusion of underrepresented groups in biomedical research. Interested applicants must adhere to strict submission guidelines via Grants.gov, with a close date for applications set for January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program (R03) aimed at supporting recipients of K01, K08, K23, and K25 awards from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This program allows eligible awardees, specifically those in their second to fourth award year who do not yet hold independent R01 grants, to request up to $100,000 in direct costs over a two-year period to enhance their research capabilities, focusing on pilot studies, methodology development, and secondary data analysis, while explicitly excluding clinical trials. The initiative is designed to foster the development of early-career scientists and strengthen the research landscape by generating additional publications and data necessary for future R01 grant applications. Interested applicants must submit their proposals by February 19, 2025, and can find more information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for small Research Project Grants (R01s) aimed at clinical trials focused on diseases under the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative encourages the submission of pilot and feasibility clinical trials that will provide foundational data for larger, definitive trials intended to improve the prevention and treatment of various health conditions, without the requirement of preliminary efficacy data. The program supports innovative research ideas and emphasizes equitable recruitment from diverse populations, with a maximum grant duration of three years and funding up to $200,000 per year. Interested applicants can find more information and submit their applications by May 7, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Small Grant Program aimed at supporting recipients of the Special Emphasis Research Career Award (SERCA) K01 who have completed the first two years of their award. This program provides funding of up to $75,000 in direct costs over a maximum period of two years to facilitate small-scale research projects, excluding clinical trials, thereby assisting awardees in transitioning to independent research roles. The initiative is part of NIH's commitment to enhancing the diversity of research talent and advancing biomedical research, particularly in veterinary science. Interested applicants from eligible organizations must adhere to submission guidelines, with applications accepted until May 7, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-127.html.
    Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a funding opportunity for small R01 grants aimed at supporting clinical trials that address diseases within its mission. This initiative encourages pilot and feasibility studies in human subjects to gather preliminary and feasibility data necessary for larger clinical trials focused on the prevention and treatment of diabetes and other related conditions. With an anticipated budget of $1 million for fiscal year 2025, NIDDK plans to fund up to three awards, each with a maximum direct cost of $200,000 annually over a three-year project period. Interested applicants must submit their proposals electronically through Grants.gov by May 7, 2026, and are encouraged to include a "Plan for Enhancing Diverse Perspectives" to promote inclusivity in their research efforts. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 recipients, aimed at supporting those who have completed the first two years of their award. This program, identified as PAR-25-176, seeks to enhance the research capabilities of SERCA K01 awardees as they transition to independent investigator status, focusing on projects such as pilot studies, feasibility studies, and methodology development, while explicitly excluding clinical trial applications. Each project may receive up to $75,000 in direct costs over a two-year period, with applications encouraged from a diverse range of eligible organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is May 7, 2026, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.